Human clinical study on plasma coenzyme Q10 concentrations
Not Applicable
- Conditions
- Healthy adults
- Registration Number
- JPRN-UMIN000043690
- Lead Sponsor
- KANEKA CORPORATIO
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Not provided
Exclusion Criteria
1.Subjects taking supplements containing CoQ10 3 months prior to the study. 2.Subjects who receiving drug treatment. 3.Subjects who participating in any other clinical study/trial or within 4 weeks after participating in another study. 4.Subjects who have history of present illness and past medical history that affect digestion and absorption of diet. 5.Subjects who cannot eat orally. 6.Subjects who are in pregnant, breast feeding, or expect to be pregnant during the study. 7.Subject who have smoking habits. 8.Subjects who continue high-intensity exercise regularly. 9.Subjects judged inappropriate for this study by the principal investigator.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method CoQ10 levels
- Secondary Outcome Measures
Name Time Method CoQ10 levels in various areas